Chronic Hepatitis C
Retinoic acid enhances the antiviral effect of interferon on hepatitis C virus
Published in Hepatitis Weekly, March 10th, 2003
According to a study from Japan, "the concentration of type I interferon receptor (IFN-Rc) in the liver is a crucial factor in determining the efficacy of interferon (IFN) therapy in patients with chronic hepatitis C."
"Retinoic acids (RAs) can enhance the expression of type I IFN-Rc expression. The aim of this study was to investigate whether RAs increase the anti-hepatitis C virus (HCV) effect of IFN through an increase in IFN-Rc," stated S. Hamamoto and coauthors, Shimane Medical University, Department of Internal Medicine 2.
"The hepatocellular...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2003-03-10)
More Articles from Hepatitis Weekly
- Chronic Hepatitis C
Immune response cells within the liver constrain hepatitis C virus load - Liver Transplantation
Switching to intramuscular hepatitis B immune globulin is safe, effective - Hepatitis C Research
Hepatitis C virus can infect and replicate in B cell lymphoma cell lines - Kidney Transplantation
Hepatitis C therapy makes long-term remission possible after transplantation - Psychiatry
Psychiatric follow-up may improve hepatitis C virus treatment tolerance - Hepatitis B Genetics
Transgenic tobacco plants carry gene for hepatitis B virus surface antigen - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
